MedTrace Logo

Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease

NCT00391833 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2006-10-24

No results posted yet for this study

Summary

We investigate the clinical efficacy of Panax ginseng in Alzheimer's disease (AD).

Conditions

Interventions

DRUG

Panax Ginseng

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Manho Kim, MD, PhD · Department of Neurology, Seoul National University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
83 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2005-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391833 on ClinicalTrials.gov